Related Experiment Video
Updated: Aug 17, 2026
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
[Cryotherapy for prostate cancer]
1Urologisk seksjon, Sykehuset Telemark, 3901 Porsgrunn. tebj@sthf.no
Background:
The paper describes the principles and technique of cryotherapy for prostate cancer.
Material And Methods:
From September 2003 to January 2005 we have treated 40 patients with localised prostate cancer. Among patients with T1-2 tumours, Gleason score < 7 and PSA < 10 ng/ml, average prostate-specific antigen (PSA) after 3 months is 0.32 (< 0.05-1.2) ng/ml. Among patients with T1-2, Gleason score > or = 7 or PSA > or = 10, average PSA after 3 months is 0.56 (< 0.05-1.9) ng/ml.
Results And Discussion:
Two patients needed intermittent catheterisation for a short period and underwent revision of the prostatic cavity. After 3 months, however, all patients had normal micturition. The prostate was not palpable in any of the patients. Our experience is encouraging and comparable to what has recently been reported from other countries.
Related Concept Videos
01:20Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...